Skip to Main content Skip to Navigation
Journal articles

The timeline of epigenetic drug discovery: from reality to dreams

Abstract : The flexibility of the epigenome has generated an enticing argument to explore its reversion through pharmacological treatments as a strategy to ameliorate disease phenotypes. All three families of epigenetic proteins-readers, writers, and erasers-are druggable targets that can be addressed through small-molecule inhibitors. At present, a few drugs targeting epigenetic enzymes as well as analogues of epigenetic modifications have been introduced into the clinic use (e.g. to treat haematological malignancies), and a wide range of epigenetic-based drugs are undergoing clinical trials. Here, we describe the timeline of epigenetic drug discovery and development beginning with the early design based solely on phenotypic observations to the state-of-the-art rational epigenetic drug discovery using validated targets. Finally, we will highlight some of the major aspects that need further research and discuss the challenges that need to be overcome to implement epigenetic drug discovery into clinical management of human disorders. To turn into reality, researchers from various disciplines (chemists, biologists, clinicians) need to work together to optimise the drug engineering, read-out assays, and clinical trial design.
Document type :
Journal articles
Complete list of metadata

https://hal-pasteur.archives-ouvertes.fr/pasteur-03036836
Contributor : Paola B Arimondo <>
Submitted on : Wednesday, December 2, 2020 - 7:25:11 PM
Last modification on : Wednesday, December 9, 2020 - 3:16:01 PM
Long-term archiving on: : Wednesday, March 3, 2021 - 8:14:57 PM

File

s13148-019-0776-0.pdf
Publication funded by an institution

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Collections

Citation

A. Ganesan, Paola Arimondo, Marianne Rots, Carmen Jeronimo, María Berdasco. The timeline of epigenetic drug discovery: from reality to dreams. Clinical Epigenetics, BioMed Central, 2019, 11 (1), pp.174. ⟨10.1186/s13148-019-0776-0⟩. ⟨pasteur-03036836⟩

Share

Metrics

Record views

30

Files downloads

48